Heart Failure in 2012 with reference to NICE Guidance Dr Maurice Pye Consultant Cardiologist York District Hospital

Similar documents
Advanced Heart Failure Management. Dr Andrew Hannah Consultant Cardiologist Aberdeen Royal Infirmary

Cardiology. Presented by: Dr Paul Bethell GP Lead for Planned Care

Checklist for Treating Heart Failure. Alan M. Kaneshige MD, FACC, FASE Oklahoma Heart Institute

Heart Failure from a GP perspective

Understanding and Development of New Therapies for Heart Failure - Lessons from Recent Clinical Trials -

Heart Failure Treatments

NT-proBNP: Evidence-based application in primary care

Heart Failure A Disease for the Internist?

Diagnosis and management of Chronic Heart Failure in 2018: What does NICE say? PCCS Meeting Issues and Answers Conference Nottingham

A patient with decompensated HF

Congestive Heart Failure: Outpatient Management

Heart Failure Management Update

ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure

Congestive Heart Failure or Heart Failure

Heart Failure Clinician Guide JANUARY 2018

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

Heart Failure Clinician Guide JANUARY 2016

Heart Failure. Jay Shavadia

NCAP NATIONAL CARDIAC AUDIT PROGR AMME NATIONAL HEART FAILURE AUDIT 2016/17 SUMMARY REPORT

Heart failure: Local solutions for a growing problem

Heart Failure in Women

8:30-10:30 WS #4: Cardiology :00-13:00 WS #11: Cardiology 101 (Repeated)

Nora Goldschlager, M.D. SFGH Division of Cardiology UCSF

Inverclyde CHP Protected Learning Event- Heart Failure

Evaluation of a diagnostic pathway in heart failure in primary care, using electrocardiography and brain natriuretic peptide guided echocardiography

Definition of Congestive Heart Failure

Women s Heart Health: Holistic Approaches Throughout the Lifetime - Key Differences in Heart Failure in Women

Review of Cardiac Imaging Modalities in the Renal Patient. George Youssef

HEART FAILURE. Study day November 2018 Sarah Briggs

ESC Guidelines for the Diagnosis and Treatment of Chronic Heart Failure

The Failing Heart in Primary Care

Congestive Heart Failure 2015

Disclosures. Advances in Chronic Heart Failure Management 6/12/2017. Van N Selby, MD UCSF Advanced Heart Failure Program June 19, 2017

HFpEF. April 26, 2018

HEART FAILURE. Study day November 2017 Sarah Briggs and Janet Laing

1000 Lives Key Components of Reliable, Evidence-Based Chronic Heart Failure Care how do we compare?

Heart Failure Acute and Chronic

Pharmacological Treatment for Chronic Heart Failure. Dr Elaine Chau HK Sanatorium & Hospital, Hong Kong 3 August 2014

Chronic. Outline. Congestive^ Heart Failure: Update on Effective Monitoring and Treatment. Heart Failure Epidemiology. Michael G.

CHF ICU to community. Disclosure slide CHF. Diagnosis. Diagnosis. Diagnostic modalties Therapeutic modalities. Talks. Advisory boards.

Medical management of LV aneurysm and subsequent cardiac remodeling: is it enough? J. Parissis Attikon University Hospital Athens, Greece

LITERATURE REVIEW: HEART FAILURE. Chief Residents

Disclosures. Overview. Goal statement. Advances in Chronic Heart Failure Management 5/22/17

Sliwa et al. JACC 2004;44:

DECLARATION OF CONFLICT OF INTEREST

HEART FAILURE. Heart Failure in the US. Heart Failure (HF) 3/2/2014

21/06/2018. MEASURING PERFORMANCE (AUDIT AND QUALITY IMPROVEMENT) Towards Reducing Inequity. What should we be measuring?

Heart Failure Management. Waleed AlHabeeb, MD, MHA Assistant Professor of Medicine Consultant Heart Failure Cardiologist

Chronic. Outline. Congestive^ Heart Failure: Update on Effective Monitoring and Treatment. Heart Failure Epidemiology

Identification of patients with heart failure and PREserved systolic Function : an Epidemiologic Regional study

The new Guidelines: Focus on Chronic Heart Failure

Heart Failure. GP Update Refresher 18 th January 2018

Chronic heart failure: management of chronic heart failure in adults in primary and secondary care (partial update)

was admitted to the Cardiology Service at the from Y /M /D to Y / M / D under the care of Dr..

CT Academy of Family Physicians Scientific Symposium October 2012 Amit Pursnani, MD

HEART FAILURE SUMMARY. and is associated with significant morbidity and mortality. the cornerstone of heart failure treatment.

Chronic. Outline. Congestive^ Heart Failure: Update on Effective Monitoring and Treatment. Heart Failure Epidemiology. Michael G.

The NEW Heart Failure Guidelines

Clinical Indications for Echocardiography

National Horizon Scanning Centre. Irbesartan (Aprovel) for heart failure with preserved systolic function. August 2008

Diastolic Heart Failure. Edwin Tulloch-Reid MBBS FACC Consultant Cardiologist Heart Institute of the Caribbean December 2012

Heart Failure 101 The Basic Principles of Diagnosis & Management

Innovation therapy in Heart Failure

Heart Failure. Dr. William Vosik. January, 2012

Coronary Heart Disease. Iqbal Malik

Cardiovascular Clinical Practice Guideline Pilot Implementation

Optimal blockade of the Renin- Angiotensin-Aldosterone. in chronic heart failure

DISCLOSURES ACHIEVING SUCCESS THROUGH FAILURE: UPDATE ON HEART FAILURE WITH PRESERVED EJECTION FRACTION NONE

Quality Payment Program: Cardiology Specialty Measure Set

Management Strategies for Advanced Heart Failure

Heart Failure. A Marvellous Story with More to Come. Prof Ken McDonald National Clinical Lead for Heart Failure

Chronic. Congestive^ Heart Failure: Update on Effective Monitoring and Treatment. Michael G. Shlipak, MD, MPH

Contemporary heart failure management. Dr Joris Mekel GP meeting 26 March 2015

New NICE Heart Failure Guidelines What do they mean for primary and secondary care, and patients?

State-of-the-Art Management of Chronic Systolic Heart Failure

Incidence. 4.8 million in the United States. 400,000 new cases/year. 20 million patients with asymptomatic LV dysfunction

MEDICAL MANAGEMENT OF PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION

HEART FAILURE: PHARMACOTHERAPY UPDATE

Aldosterone Antagonism in Heart Failure: Now for all Patients?

Medical Treatment for acute Decompensated Heart Failure. Vlasis Ninios Cardiologist St. Luke s s Hospital Thessaloniki 2011

Therapeutic Targets and Interventions

Heart Failure Management Policy and Procedure Phase 1

I have no disclosures. Disclosures

Heart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output

Outline. Chronic Heart Failure: Update on Effective Monitoring and Treatment. Heart Failure Epidemiology. Michael G.

Severe Hypertension. Pre-referral considerations: 1. BP of arm and Leg 2. Ambulatory BP 3. Renal causes

Younger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.

Heart Failure (HF) - Primary Care Flow Charts. Pre diagnosis Symptoms or signs suggestive of HF

Heart Failure (HF) - Primary Care Flow Charts. Symptoms or signs suggestive of HF. Pre diagnosis. Refer to the Heart Failure Clinic at VHK for

Heart Failure New Drugs- Updated Guidelines

Heart Failure with Reduced EF. Dino Recchia, MD, FACC, FHFSA

What s new in 2016 Guidelines of the European Society of Cardiology? HEART FAILURE. Marc Ferrini (Lyon Fr)

Sara O. Weiss, MD Director, Heart Failure Services Virginia Mason Medical Center September 8, 2012

CKD Satellite Symposium

Atrial Fibrillation and Heart failure

Heart Failure Dr ahmed almutairi Assistant professor internal medicin dept

Beta-blockers in heart failure: evidence put into practice

The ACC Heart Failure Guidelines

Hypertension and Atrial Fibrillation in 2017

Transcription:

Heart Failure in 2012 with reference to NICE Guidance 2010 Dr Maurice Pye Consultant Cardiologist York District Hospital

A little over elaborate,do not include ECG or CXR If clinical suspicion is high (or( any h/o MI) ) refer for an echocardiogram or consultant cardiology opinion If uncertain then ECG,Chest X ray + BNP are reasonable if all normal then not heart failure! BNP very good rule out test - ie few false negatives if its not raised then unlikely heart failure but non specific ie fair no of false positives raised in COPD, cor pulmonale,, AF, valvular heart disease, renal disease, sepsis, LVH, diabetes UNLESS Very high

NEW 2 week referral guide for secondary care If BNP vey high If any history of Myocardial Infarction

CXR in the diagnosis of heart failure: Cardiothoracic ratio > 50% is specific, not sensitive Useful to exclude other causes of SOB

ECHO in the diagnosis of heart failure: Best test for assessment LV systolic dysfunction Of those on HF treatment only 25% have significant LV Only 25% referred from 1 o care have LV systolic dysfunction Only 8%? New heart failure had LV systolic dysfunction?diastolic dysfunction and heart failure

Perform Perform transthoracic Doppler 2D echocardiography to exclude important valve disease, assess systolic (and diastolic) function n of the (left) ventricle, and detect intracardiac shunts. Ensure that: echocardiography is performed on high-resolution equipment by experienced trained operators (+- contrast echo) demand does not compromise quality those reporting echocardiography are experienced in doing so. - When a poor image is produced by transthoracic Doppler 2D echocardiography, consider other imaging methods, such as radionuclide angiography, cardiac magnetic resonance imaging or transoesophageal Doppler 2D echocardiography.

Establish diagnosis of what type of heart failure Exclude following as as mimickers of irreversible or fixed LV dysfunction Significant valvular heart disease esp MR or AS Dysrhythmias AF tachycardiomyopathy Ischaemia Alchohol Catecholamines - Phaeochromocytoma Hereditary cardiomyopathies Pericardial disease

Life style alchohol abstinence best, smoking cessation, Exercise and rehab with educational component for patient to manage his condition Aspirin for patients with IHD only Warfarin if in AF very strong indication some patients with SR Depression/ anxiety common often need treatment in their own right

Other general measures for heart failure Risk factor management obesity hypertension Salt reduction( 3g/day) Avoid Calcium antagonists, NSAIDs,, Anti-arrhythmics Other Flu vacc, Pneumococcal vacc

Drug treatment of Heart Failure Diuretics usually loop diuretic frusemide or bumetamide ACE inhibitor eg generic ramipril Or Angiotensin 2 blockade generic losartan ONLY IF true allergy to ACE or definite ACE cough (very rarely combined) Or hydrallazine +- nitrate if intolerant to both OR African/Caribbean

Drug treatment of Heart Failure 2 Beta blockers uptitrate weekly when euvolaemic Spironolactone/Eplenerone (Aldosterone antagonists) Monitor Creatinine/Potassium 1-21 2 weeks post Digoxin still can be useful even in SR obviously quite narrow therapeutic window CRT Bi Ventricular Pacing +-+ ICD therapy DEVICE THERAPY CRT

Lives saved with Rx in LV failure TRIAL Lives saved/1000/year HOPE ACE in IHD <1 SOLVD-P ACE in LVSD 7 SOLVD-R ACE in low EF 17 MERIT CIBIS Beta B in LVSD 38 Beta B in LVSD 42 RALES Spironolactone 52 COPERNICUS BB severe LV 70

The 1 st large major study of Ivabradine V placebo = Beautiful Study NEGATIVE no benefit The 2 nd study = SHIFT study showed NO effect on mortality but significantly reduced hospital admissions for heart failure So perhaps could consider this drug in more severe heart failure if beta blocker contraindicated or could not get to reasonable dose of bisoprolol ie 5 mg AND HR still > 70 /min and no BiV pacing